SERUM EQUILIN, ŒSTRONE, AND ŒSTRADIOL LEVELS IN POSTMENOPAUSAL WOMEN RECEIVING CONJUGATED EQUINE ŒSTROGENS ('PREMARIN')

The Lancet

Volumn 315, Issue 8158, 1980, Pages 14-16

  Whittaker, P G ^a   Morgan, M R A ^a   Dean, P D G ^a   Cameron, E H D ^b   Lind, T ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Regional Hormone Laboratory ^*  (United Kingdom)

^c Princess Mary Maternity Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; EQUILIN; ESTRADIOL; ESTRONE; 17 KETOSTEROIDS; 17 OXOSTEROID; NORETHISTERONE;

DRUG BLOOD LEVEL; DRUG COMPARISON; DRUG THERAPY; ENDOMETRIUM CANCER; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; ESTRONE BLOOD LEVEL; FEMALE GENITAL SYSTEM; HORMONAL THERAPY; HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRELIMINARY COMMUNICATION; RADIOIMMUNOASSAY; THERAPY; ADULT; ARTICLE; BLOOD; CASTRATION; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MENOPAUSE; POSTOPERATIVE CARE; TIME; UTERUS CANCER;

17-KETOSTEROIDS; CASTRATION; EQUILIN; ESTRADIOL; ESTROGENS, CONJUGATED; ESTRONE; FEMALE; HUMAN; MENOPAUSE; MIDDLE AGE; NORETHINDRONE; POSTOPERATIVE CARE; TIME FACTORS; UTERINE NEOPLASMS;

EID: 0018909058     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(80)90552-8     Document Type: Article

References (14)

1. Association of exogenous estrogen and endometrial cancer
2. Increased risk of endometrial carcinoma among users of conjugated estrogens
3. Estrogens and endometrial cancer in a retirement community
4. Exogenous estrogen and endometrial carcinoma: case control and incidence study
5. Endometrial cancer and estrogen use
6. Replacement estrogens and endometrial cancer
7. Evaluation of equilin-3-monosulphate and other estrogens
8. A prospective controlled trial of six forms of hormone replacement therapy given to post-menopausal women
9. Some observations on the measurement of estradiol 17β in human plasma by radioimmunoassay
10. Endometrial histology, uterine bleeding and estrogen levels in menopausal women receiving estrogen therapy and estrogen/progestagen therapy
11. Plasma levels of oestrone oestradiol and gonadotrophins in post-menopausal women after oral and vaginal administration of conjugated equine œstrogens (Premarin)